Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy

Table 2 Results of hepatitis B virus reactivation in patients with hepatocellular carcinoma receiving hepatectomy n (%)

Ref.	No of patients	HBV reactivation1	Morbidity/mortality
Kubo et al[36]	25	28.0%	24% had postoperative hepatitis
Huang et al[35]	164	21.1%	No patient developed liver failure postoperation
Huang et al[37]	84	31.8%	8.3% had postoperative liver insufficiency
Dan et al[38]	93	14.0%	25% developed hepatitis, None of them developed hepatic failure
Lao et al[30]	121	15.7%	26 (8.1) had liver functional deterioration

¹The rates of hepatitis B virus (HBV) reactivation were the frequencies in antiviral-untreated patients.